Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Kang, Yoon-Koo Boku, Narikazu Satoh, Taroh Ryu, Min-Hee Chao, Yee Kato, Ken Chung, Hyun Cheol Chen, Jen-Shi Muro, Kei Kang, Won Ki Yeh, Kun-Huei Yoshikawa, Takaki Oh, Sang Cheul Bai, Li-Yuan Tamura, Takao Lee, Keun-Wook Hamamoto, Yasuo Kim, Jong Gwang Chin, Keisho Oh, Do-Youn Minashi, Keiko Cho, Jae Yong Tsuda, Masahiro Chen, Li-Tzong